This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Lupus Research Leaders Join Forces To Bring Vital Biomedical Research Issues To Congress

Together Voice Critical Need for Federal Appropriations to Support Lupus Research and Advance New Treatments

WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- America's leading proponents for lupus research came together today to host a Congressional briefing to update the U.S. Senate and House of Representatives on the pressing needs of the 1.5 million Americans living with lupus -- the prototypical autoimmune disease.

As sequestration imminently threatens funding for scientific research to advance new drug development and a cure, the plight of those suffering with lupus, particularly in underserved communities, is stark.  To bring patients' voices to the fore, the Lupus Research Institute (LRI) in collaboration with the Alliance for Lupus Research and the American Autoimmune Related Diseases Association hosted the briefing along with long-time lupus champion Senator Frank Lautenberg (D-NJ) and the Congressional Lupus Caucus .

"The lupus community has united today to bring federal attention to our common cause, and we are deeply grateful to Senator Lautenberg and members of the Congressional Lupus Caucus for their help in raising awareness of lupus among their colleagues on the Hill," commented Margaret Dowd, president and CEO of the Lupus Research Institute.  "Together we call upon all members of Congress to strengthen support for biomedical research at the National Institutes of Health (NIH). Privately funded research is the engine for discovery. But we need sustained and dependable long-term growth in NIH-funded medical research to turn innovation into new treatments and cures."

Sharing his experience seeing lupus patients every day, Dr. Robert Katz at Rush University Medical Center and Northwestern Memorial Hospital in Chicago outlined the devastation this autoimmune disease causes for patients and families. "When you see a lupus patient who doesn't look sick, it's hard to imagine she suffers from a disease causing such fatigue and pain that she literally cannot make it to work or pick up her child from school. But behind that healthy face is an immune system run amok, attacking her own body at random. Striking any organ and tissue, lupus is a leading cause of heart attack, stroke and kidney disease among young women."

Protecting the Scientific Progress of the Past Decade  Dr. Mary Crow, Physician-in-Chief and Chair of the Division of Rheumatology at Hospital for Special Surgery delivered a powerful presentation on the importance of federal funding to sustain biomedical research at the NIH in lupus and other autoimmune diseases.   "We must protect the invaluable progress of lupus research over the last decade and cannot lose ground at this pivotal juncture when solutions to this confounding disease are finally within reach," noted Dr. Crow.

Lupus, a Serious Minority and Women's Health Issue Speaking about health and racial disparities in lupus, Dr. Betty Diamond of The Feinstein Institute for Medical Research and Albert Einstein College of Medicine in NY provided data disputing widely-held assumption about minorities and clinical research. "Research shows that people of color are just as receptive to participating in clinical trial studies as Caucasians," said Dr. Diamond. "The obstacle is not so much overcoming patient resistance as has been commonly assumed, but rather for healthcare professionals to abandon their preconceptions and invite lupus patients of all races and ethnicities to participate in clinical trials."

Time to Speak Out  In addition to hosting the briefing, the LRI and patient advocacy groups from throughout the country visited Congressional representatives, conveying three key requests for federal support:

"Now is the moment to be heard, when critical decisions will affect the future of biomedical research, an urgent need that cannot wait," Ms. Dowd emphasized. "Join our grassroots campaign to stop budget cuts from crippling NIH funding for the studies needed to deliver improved treatments for people with lupus and other autoimmune diseases. Please visit LupusResearchInstitute.org or Facebook.com/lupusresearch to send a strong message to Congressional legislators."

About Lupus and Autoimmune Diseases A complex autoimmune disease, lupus affects over 1.5-million Americans, primarily young women and women of color.  One in every five people suffers from a type of autoimmune disease.

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs